Arcus Biosciences (RCUS) Current Taxes (2021 - 2022)

Arcus Biosciences' (RCUS) quarterly Current Taxes came in at $18000.0 in Q3 2022, little changed quarter-over-quarter from $18000.0 in Q2 2022.

Arcus Biosciences (RCUS) Current Taxes (2021 - 2022) Analysis & Trends

Arcus Biosciences' Current Taxes history runs 2 years deep, the most recent figure standing at $18000.0 for Q3 2022.

On a quarterly basis, Current Taxes changed N/A year-over-year to $18000.0 in Q3 2022; TTM through Sep 2022 was $18000.0, a N/A change from a year earlier, with the FY2021 full-year figure at $2.0 million, changed N/A from the prior year.
Current Taxes held at $18000.0 in Q3 2022 per RCUS's latest filing, from $18000.0 in the prior quarter.
Across five years, Current Taxes topped out at $2.8 million in Q1 2022 and bottomed at $18000.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	63.52 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	49.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Arcus Biosciences	3.73 Bn	2.90 Bn	-	-

Download Data